BeOne Medicines
ONC
#652
Rank
NZ$68.02 B
Marketcap
NZ$601.32
Share price
-2.07%
Change (1 day)
8.02%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): NZ$8.25

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$8.35. In 2025 the company made an earnings per share (EPS) of NZ$4.74 an increase over its 2024 EPS that were of NZ-$10.83.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$8.2574.1%
2025NZ$4.74-143.75%
2024NZ-$10.83
2022NZ-$33.8428.21%
2021NZ-$26.40-19.96%
2020NZ-$32.9820.81%
2019NZ-$27.3031.52%
2018NZ-$20.76417.57%
2017NZ-$4.01-37.16%
2016NZ-$6.38158.95%
2015NZ-$2.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.47-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.65-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA